Zobrazeno 1 - 10
of 788
pro vyhledávání: '"F. BARALLE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Munteanu, Cătălin Vasile1,2 (AUTHOR) catalin.munteanu@umft.ro, Marian, Cătălin3,4,5 (AUTHOR), Chiriță-Emandi, Adela2,6,7 (AUTHOR), Puiu, Maria2,6,7 (AUTHOR), Trifa, Adrian Pavel4,5,6,8 (AUTHOR)
Publikováno v:
BMC Genomic Data. 11/27/2024, Vol. 25 Issue 1, p1-14. 14p.
Autor:
Sadeghi Shaker, Mina1,2 (AUTHOR), Rokni, Mohsen1,2,3 (AUTHOR), Kavosi, Hoda2,4 (AUTHOR), Enayati, Samaneh2 (AUTHOR), Madreseh, Elham2,5 (AUTHOR), Mahmoudi, Mahdi2,4 (AUTHOR), Farhadi, Elham2,4 (AUTHOR) farhadie@tums.ac.ir, Vodjgani, Mohammad1 (AUTHOR) vojganim@tums.ac.ir
Publikováno v:
Immunity, Inflammation & Disease. Nov2024, Vol. 12 Issue 11, p1-10. 10p.
Autor:
Daniela Vitulli, M. Gerotto, Mario Pirisi, M. Del Forno, Edmondo Falleti, Carlo Fabris, Giorgio Soardo, F. Baralle, Pierluigi Toniutto, Ettore Bartoli, S. G. Tisminetzky
Publikováno v:
Digestive Diseases and Sciences. 42:767-771
To verify its value with regard to the outcomeof therapy in chronic hepatitis C, seruminterferon-α (IFN) was measured by ELISA in 70patients (43 male, 27 female) with chronic hepatitis C,treated with IFN 9 MU/week subcutaneously for up to oneyear. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56a0ef8a090730fd003cabfc043618d0
https://doi.org/10.1023/a:1018808012823
https://doi.org/10.1023/a:1018808012823
Publikováno v:
The Lancet. 344:1679-1682
The development of intravenous enzyme-replacement treatment for Gaucher's disease has changed life expectancy in cases without neurological involvement (type 1). The effects in patients with neurological involvement are unknown. We treated 12 Italian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840f0854543769d521666ad4e4e7166f
https://doi.org/10.1016/s0140-6736(94)90462-6
https://doi.org/10.1016/s0140-6736(94)90462-6
Autor:
Ding, Qiliang1 (AUTHOR), Hofich, Christopher D.1 (AUTHOR), Kellogg, Tifani B.1 (AUTHOR), Kuennen, Rhonda K.1 (AUTHOR), Paxton, Kaitlin N.1 (AUTHOR), Thieke, Sarah M.1 (AUTHOR), Rumilla, Kandelaria M.1 (AUTHOR), Hasadsri, Linda1 (AUTHOR) hasadsri.linda@mayo.edu
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8533. 12p.
Autor:
Mahmoodi, Mahdokht1 (AUTHOR), Mirzarazi Dahagi, Elahe2 (AUTHOR), Nabavi, Mir‐Hamed1 (AUTHOR), Penalva, Ylauna C. M.3,4 (AUTHOR), Gosaine, Amrita2 (AUTHOR), Murshed, Monzur1,5 (AUTHOR), Couldwell, Sandrine1 (AUTHOR), Munter, Lisa M.3,4 (AUTHOR), Kaartinen, Mari T.1,2,6 (AUTHOR) mari.kaartinen@mcgill.ca
Publikováno v:
Physiological Reports. Jul2024, Vol. 12 Issue 14, p1-21. 21p.
Malattia Leventinese (ML) is a dominant macular dystrophy characterized by drusen at the posterior pole. ML has been associated with a single mutation (R345W) in the EGF-containing. fibulin-like extracellular matrix protein 1 (EFEMP-1) gene, but also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::51f858b9af259189cc854b0e617436ba
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.